An interventional study of Intervention: Reusable drapes and gowns and Comparator: Disposable (single-use) drapes and gowns in Surgical Site Infection, sponsored by University of Birmingham. Recruiting at 7 sites in 7 countries. Open to participants aged 10 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by University of Birmingham · Not applicable, Interventional, and Other
Benin, Ghana, India, Nigeria, Rwanda, South Africa
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Multicentre non-inferiority cluster randomised trial testing Disposable versus Reusable drApes and Gowns for green OperatiNg theatres. A pragmatic 1:1 international multi-centre non-inferiority cluster randomised controlled trial, with an internal pilot. Clusters are individual hospitals.
Background: The World Health Organisation makes no recommendation for the use of disposable or reusable surgical drapes and gowns due to a lack of effectiveness evidence. Since disposable versions are likely to have higher financial and carbon costs, they are only justifiable if they can be proven to significantly reduce surgical site infections (SSIs).
Aim: This randomised controlled trial will assess whether reusable surgical drapes and gowns are non-inferior in reducing SSI compared to disposable drapes and gowns in patients undergoing surgery.
Design: Pragmatic 1:1 international multi-centre non-inferiority cluster randomised controlled trial, with an internal pilot. Clusters are individual hospitals.
Intervention: Reusable surgical drapes and gowns.
Comparator: Disposable (single-use) surgical drapes and gowns.
Sample size: The control group SSI event rate is estimated to be 12.5% based on previous literature. To determine whether reusable drapes and gowns are non-inferior to disposable drapes and gowns with a non-inferiority margin of 2.5% would require a total of 26,800 participants from 134 clusters, with an average of 200 participants per cluster, assuming 90% power, 2.5% one-sided alpha, intraclass correlation of 0.01 and 5% participant loss to follow up.
747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.
This study's planned enrollment of 26,800 is above the median of 200 across 583 interventional studies indexed under Surgical Wound Infection.
Browse Surgical Wound Infection studies →University of Birmingham is the lead sponsor of 182 studies on the registry; 28 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
* Reusable drapes and gowns are made from cotton and polyester and are protective against fluid contamination and, to a certain extent, mechanical stress. * Reusable drapes and gowns are usually autoclaved and laundered using pressurised steam. This ensures that bacteria and other microorganisms are killed, sterilising the fabric so it is suitable for re-use. In this pragmatic trial, a specific sterilisation protocol is not mandated, but details of the sterilisation processes in place at each hospital will be captured in the Hospital-level Questionnaire before site opening. We may report this in a paper ahead of the main trial publication.
Other: Intervention: Reusable drapes and gowns
* Single-use surgical gowns and drapes are generally made from non-woven plastic polymers that are protective against fluid contamination and, to a certain extent, mechanical stress. * They are intended for use during a single operation and are then disposed of as biohazard waste for incineration. * Typically, four drapes are needed for an abdominal operation (two larger and two smaller drapes), although more may be needed for some procedures. * A range of disposable gowns are available. The choice of disposable gown will be at the hospital PI's discretion and will be captured in the Hospital-level Questionnaire.
Other: Comparator: Disposable (single-use) drapes and gowns
Reusable drapes and gowns used during surgery.
Disposable drapes and gowns used during surgery.
Surgical site infection (SSI)
SSI according to centre for disease control (CDC) criteria: The infection must occur within 30-days of the index operation AND The infection must involve the skin, subcutaneous, muscular, or fascial layers of the incision AND The patient must have at least one of the following: Purulent drainage from the wound Organisms are detected from a wound swab Wound opened spontaneously or by a clinician AND, at the surgical wound, the patient has at least one of pain or tenderness; localised swelling; redness; heat; systemic fever (\>38°C). Diagnosis of SSI by a clinician or on imaging
Time frame: Within 30 days of surgery
Mortality (and likely cause)
Time frame: Within 30 days of surgery
Unplanned wound opening
Time frame: Within 30 days of surgery
Antibiotic prescribing for SSI
Time frame: Within 30 days of surgery
Reattendance at emergency department
Time frame: Within 30 days of surgery
Readmission to hospital
Time frame: Within 30 days of surgery
Reoperation for SSI
Time frame: Within 30 days of surgery
Total length of hospital stay
Time frame: Within 30 days of surgery
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Plan to share: No — Hospital-level data will not be released or published. Country-level analyses will only be conducted with permission of lead investigators from each participating country. Local investigators may access their data across their country to perform country-level analyses (all participating hospitals should consent to their data being used in this way).
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Jun 2027, 31 months after the start.
Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 31 months is above that.
Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jun 2026 → Jun 2027 and completion Jul 2026 → Jul 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Benin, Ghana, India, Nigeria, Rwanda, South Africa
Benin, Ghana, India, Nigeria, Rwanda, South Africa
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.